Elizabeth Plimack
0000-0002-7618-0744
4 papers found
Refreshing results…
A phase 1 study of nivolumab in combination with interferon-gamma for patients with advanced solid tumors
Putative Biomarkers of Clinical Benefit With Pembrolizumab in Advanced Urothelial Cancer: Results from the KEYNOTE-045 and KEYNOTE-052 Landmark Trials
Pembrolizumab as First-line Therapy in Cisplatin-ineligible Advanced Urothelial Cancer (KEYNOTE-052): Outcomes in Older Patients by Age and Performance Status
Mutational patterns in chemotherapy resistant muscle-invasive bladder cancer
Missing publications? Search for publications with a matching author name.